Daniel Bradbury is Director of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 13,291 shares of CSTL, which is worth approximately $289,345. The most recent transaction as insider was on May 25, 2024, when has been sold 8,636 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3K
185.52% 3M change
185.52% 12M change
Total Value Held $289,345

DANIEL BRADBURY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2024
BUY
Exercise of conversion of derivative security
-
8,636 Added 39.39%
13,291 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
-
3,825 Added 45.11%
4,655 Common Stock
Jun 10 2022
BUY
Exercise of conversion of derivative security
-
830 Added 50.0%
830 Common Stock

Also insider at

NUVB
Nuvation Bio Inc. Healthcare
ICPT
INTERCEPT PHARMACEUTICALS, INC. Healthcare
EYES
SECOND SIGHT MEDICAL PRODUCTS INC Healthcare
EQ
Equillium, Inc. Healthcare
DB

Daniel Bradbury

Director
Friendswood, TX

Track Institutional and Insider Activities on CSTL

Follow CASTLE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL